Chronic Pain Management: Multimodal Best Practices for Community-Based Clinicians
- Credit Type
- CME
- Credit Amount
- 1
- Release Date
- 11/01/2011
- Expiration Date
- 11/01/2012
- Activity Type
- Videocast
Jointly sponsored by Purdue University College of Pharmacy and Asante Communications, LLC
This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com
Activity Goal
Employing a case-based live patient and digital format, this activity aims to disseminate best practices in the individualized assessment, diagnosis, and management of patients with chronic pain.
Intended Audience
This educational activity is intended for a multidisciplinary audience of clinicians, including pain specialists, primary care physicians, physician assistants, nurse practitioners, and other healthcare providers interested in chronic pain management.
There are no prerequisites for this educational activity.
Overview
More than 50 million people in the United States suffer from chronic pain syndromes, and nearly half of the population will seek treatment for persistent pain at some point in their lifetimes. In fact, numerous epidemiologic studies have estimated an annual cost of $80 billion in the United States alone. This reflects the serious consequences of chronic pain on multiple functional and quality of life domains—affective, cognitive, physical, and occupational. Yet chronic pain is woefully underdiagnosed and undertreated. Once regarded as a symptom of underlying disorders, the neuroplastic changes that characterize chronic pain are now believed to constitute a heterogeneous disease state, requiring targeted assessment and management. All healthcare providers should therefore be prepared to differentially diagnose chronic pain syndromes, including low back pain, osteoarthritis, and neuropathic disorders, among others. Assessment must reflect the multidimensional nature of chronic pain and treatment should target underlying disease mechanisms as much as possible. This online multimedia continuing education activity highlights practical assessment and treatment strategies for different chronic pain syndromes, including a live patient demonstration of approaches to facilitate a thorough yet concise evaluation of low back pain, reflecting time constraints often faced by primary care clinicians.
Learning Objectives
At the completion of this initiative, participants should be better prepared to:
1. Explain salient pathophysiologic events underlying chronic pain and their practical considerations for treatment
2. Conduct initial and ongoing multidimensional assessment of patients with chronic pain
3. Evaluate evidence-based approaches supporting diagnostic and treatment modalities for chronic pain syndromes
4. Individualize multidrug strategies based on differential diagnosis, inferred pathophysiology, patient prior medical history, comorbidities, level of function, and treatment goals
5. Formulate multimodal treatment strategies tailored to the complex pain symptomatology of patients, their psychosocial determinants, and affected functional domains
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy and Asante Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Purdue University College of Pharmacy designates this enduring educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Conflict of Interest Statement
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
Douglas C. Schottenstein, MD Endo Pharmaceuticals, Pfizer Inc. (speakers bureau)
David M. Simpson, MD, FRCP, FAAN Astellas Pharma Inc. (Consultant, Speakers Bureau); Forest Laboratories, Inc. (Consultant); Lilly USA, LLC (Consultant, Speakers Bureau); NeurogesX (Consultant, Speakers Bureau); Pfizer, Inc. (Research, Speakers Bureau)
All additional planning committee members, Purdue University College of Pharmacy staff, and Asante Communications, LLC, staff have no relevant financial relationships to disclose.
Method of Participation
There are no fees for participating in and receiving credit for this activity. The Participant will have two opportunities to obtain a score of at least 70% to successfully complete this activity. Credit is available through November 1, 2012.
Disclaimer
The opinions, ideas, recommendations, and perspectives expressed in the accompanying materials are those of the authors and faculty only and do not necessarily reflect the opinions, ideas, recommendations, or perspectives of their affiliated institutions, Purdue University College of Pharmacy, Asante Communications, LLC, or the activity’s commercial supporter.
Copyright Information
Copyright © 2011 Purdue University College of Pharmacy and Asante Communications, LLC. All rights reserved. No part of this report may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embedded in articles or reviews.
Faculty
